Stay updated with breaking news from Evaluate Safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hess Shareholders Approve $53 Billion Merger With Chevron Stockholders' approval clears one hurdle for the tie-up to happen but a challenge by Exxon makes the final outcome uncertain. Adam...
Hess Shareholders Give Approval to $53 Billion Merger With Chevron Investors' green light clears one hurdle for the tie-up to happen but a challenge by Exxon makes the final outcome uncertain....
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric and adult patients Gastroenteropancreatic neuroendocrine...
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17)...
This approval makes lutetium Lu177 the first therapy to be approved for the treatment of gastroenteropancreatic neuroendocrine tumors in pediatric patients.